© 1998 by Oxford University Press and the Maryland Psychiatric Research Center (MPRC)
Using an Animal Model of Deficient Sensorimotor Gating to Study the Pathophysiology and New Treatments of Schizophrenia
Assistant Professor, Department of Psychiatry, University of California at San Diego La Jolla, CA
Professor in Residence, Department of Psychiatry, University of California at San Diego La Jolla, CA
Reprint requests should be Sent to Dr. N.R. Swerdlow, Dept. of Psychiatry, University of California at San Diego, 9500 Gilman Dr., La Jolla, CA 92093-0804
Certain animal models can greatly enhance our understanding of the neurobiology of schizophrenia and can be used to predict the antipsychotic activity of compounds. Prepulse inhibition (PPI), the reduction in startle produced by a prepulse stimulus, is diminished in schizophrenia patients. Theoretically, deficient PPI in schizophrenia patients is a measure of the loss of sensorimotor gating that may lead to sensory flooding and cognitive fragmentation. In rats, PPI is disrupted by systemic administration of dopamine agonists, serotonin agonists, or glutamate antagonists and by a variety of surgical or pharmacological manipulations of neural circuitry linking the limbic cortex, striatum, pallidum, and pontine reticular formation. This article describes several different ways the loss of PPI in rats can be used as a model for studying the pathophysiology and neurobiology of impaired sensorimotor gating in schizophrenia patients and for predicting antipsychotic activity in novel compounds. First, new experimental strategies may be used to distinguish behavioral profiles of "typical" versus "atypical" antipsychotics. Second, this paradigm can be used to study the effects of early developmental insults—including neonatal lesions and isolated rearing—on the adult emergence of deficient sensorimotor gating. Third, using different animal strains and species, as well as gene "knockout" strategies, greatly increases our ability to understand specific genetic or receptor contributions to the regulation of deficient PPI. Each of these uses of the PPI paradigm is enhanced by studies of the basic brain substrates that regulate PPI in rats and by the increasingly sophisticated assessments of PPI and related measures in schizophrenia spectrum patients.
Keywords: Animal models / antipsychotics / prepulse inhibition / sensorimotor gating
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. Wallen-Mackenzie, K. Nordenankar, K. Fejgin, M. C. Lagerstrom, L. Emilsson, R. Fredriksson, C. Wass, D. Andersson, E. Egecioglu, M. Andersson, et al. Restricted Cortical and Amygdaloid Removal of Vesicular Glutamate Transporter 2 in Preadolescent Mice Impacts Dopaminergic Activity and Neuronal Circuitry of Higher Brain Function J. Neurosci., February 18, 2009; 29(7): 2238 - 2251. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. B. Quednow, M. Wagner, R. Mossner, W. Maier, and K.-U. Kuhn Sensorimotor Gating of Schizophrenia Patients Depends on Catechol O-Methyltransferase Val158Met Polymorphism Schizophr Bull, July 17, 2008; (2008) sbn088v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Neumeister, T. M. Szabo, and T. Preuss Behavioral and Physiological Characterization of Sensorimotor Gating in the Goldfish Startle Response J Neurophysiol, March 1, 2008; 99(3): 1493 - 1502. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Mizuno, H. Sotoyama, E. Narita, H. Kawamura, H. Namba, Y. Zheng, T. Eda, and H. Nawa A Cyclooxygenase-2 Inhibitor Ameliorates Behavioral Impairments Induced by Striatal Administration of Epidermal Growth Factor J. Neurosci., September 19, 2007; 27(38): 10116 - 10127. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Ferrarelli, R. Huber, M. J. Peterson, M. Massimini, M. Murphy, B. A. Riedner, A. Watson, P. Bria, and G. Tononi Reduced Sleep Spindle Activity in Schizophrenia Patients Am J Psychiatry, March 1, 2007; 164(3): 483 - 492. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Tanaka, N. Shintani, H. Hashimoto, N. Kawagishi, Y. Ago, T. Matsuda, R. Hashimoto, H. Kunugi, A. Yamamoto, C. Kawaguchi, et al. Psychostimulant-induced attenuation of hyperactivity and prepulse inhibition deficits in Adcyap1-deficient mice. J. Neurosci., May 10, 2006; 26(19): 5091 - 5097. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Barrett, R. Bell, D. Watson, and D. J. King Effects of Amisulpride, Risperidone and Chlorpromazine on Auditory and Visual Latent Inhibition, Prepulse Inhibition, Executive Function and Eye Movements in Healthy Volunteers J Psychopharmacol, June 1, 2004; 18(2): 156 - 172. [Abstract] [PDF]
|
|
|
|
 |
|
 A. R. Aron, F. Schlaghecken, P. C. Fletcher, E. T. Bullmore, M. Eimer, R. Barker, B. J. Sahakian, and T. W. Robbins Inhibition of subliminally primed responses is mediated by the caudate and thalamus: evidence from functional MRI and Huntington's disease Brain, March 1, 2003; 126(3): 713 - 723. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. S. Woodruff-Pak and T. J. Gould Neuronal nicotinic acetylcholine receptors: involvement in Alzheimer's disease and schizophrenia. Behav Cogn Neurosci Rev, March 1, 2002; 1(1): 5 - 20. [Abstract] [PDF]
|
|